Labcorp Holdings Inc. ( LH) - Stock Earnings
LH Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 23, 2026, midnight | — / — | — | — / — | — |
LH Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 261.1 million USD | 3.6 billion USD |
| 2025Q4 | 164.7 million USD | 3.5 billion USD |
| 2026Q1 | 277.8 million USD | 3.5 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
LH Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 418.0 million USD | 12.2 billion USD |
| 2024 | 746.0 million USD | 13.0 billion USD |
| 2025 | 876.5 million USD | 14.0 billion USD |
| 2026 Est. | — | — |
LH
Price: $279.50
Dividend Yield: 1.00%
Forward Dividend Yield: 1.03%
Payout Ratio: 53.43%
Dividend Per Share: 2.88 USD
Earnings Per Share: 11.28 USD
P/E Ratio: 22.78
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 347600
Ebitda: 501.8 millionMarket Capitalization: 23.5 billion
Average Dividend Frequency: 4
Years Paying Dividends: 5
DGR3: 30.00%